A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2-Altered Advanced Solid Tumor Malignancies (NCI 10170)
WEE1抑制剂Adavosertib治疗SETD2改变的晚期实体瘤恶性肿瘤的II期试验（NCI 10170）
期刊:Cancer Research Communications
影响因子:3.3
doi:10.1158/2767-9764.CRC-24-0213
Maldonado, Edward; Rathmell, W Kimryn; Shapiro, Geoffrey I; Takebe, Naoko; Rodon, Jordi; Mahalingam, Devalingam; Trikalinos, Nikolaos A; Kalebasty, Arash R; Parikh, Mamta; Boerner, Scott A; Balido, Celene; Krings, Gregor; Burns, Timothy F; Bergsland, Emily K; Munster, Pamela N; Ashworth, Alan; LoRusso, Patricia; Aggarwal, Rahul R
